AST SpaceMobile Valuation
Is ASTS * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ASTS * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ASTS * (MX$545) is trading below our estimate of fair value (MX$15642.32)
Significantly Below Fair Value: ASTS * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ASTS *?
Other financial metrics that can be useful for relative valuation.
| What is ASTS *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$7.68b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 3153.2x |
| Enterprise Value/EBITDA | -27.7x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does ASTS *'s PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 22.2x | ||
SITES1 A-1 Operadora de Sites Mexicanos. de | 1.8x | 50.9% | Mex$50.8b |
LBTY.A Liberty Global | 0.4x | 47.1% | US$7.2b |
LUMN Lumen Technologies | 13.1x | 70.1% | US$5.5b |
LASITE B-1 Sitios Latinoamérica. de | 73.7x | n/a | Mex$12.3b |
ASTS * AST SpaceMobile | 29x | 75.9% | Mex$7.7b |
Price-To-Book vs Peers: ASTS * is expensive based on its Price-To-Book Ratio (29x) compared to the peer average (22.2x).
Price to Earnings Ratio vs Industry
How does ASTS *'s PE Ratio compare vs other companies in the Global Telecom Industry?
Price-To-Book vs Industry: ASTS * is expensive based on its Price-To-Book Ratio (29x) compared to the Global Telecom industry average (1.8x).
Price to Book Ratio vs Fair Ratio
What is ASTS *'s PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 29x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate ASTS *'s Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$545.00 | Mex$739.61 +35.7% | 42.2% | Mex$1,226.84 | Mex$292.10 | n/a | 5 |
| Sep ’25 | Mex$649.00 | Mex$590.62 -9.0% | 36.1% | Mex$910.32 | Mex$297.49 | n/a | 5 |
| Aug ’25 | n/a | Mex$317.74 0% | 21.0% | Mex$405.94 | Mex$239.87 | n/a | 5 |
| Jul ’25 | n/a | Mex$285.01 0% | 21.4% | Mex$402.46 | Mex$235.99 | n/a | 5 |
| Jun ’25 | n/a | Mex$244.40 0% | 33.4% | Mex$373.91 | Mex$118.97 | n/a | 5 |
| May ’25 | n/a | Mex$215.25 0% | 37.1% | Mex$322.53 | Mex$118.83 | n/a | 5 |
| Apr ’25 | n/a | Mex$226.94 0% | 43.6% | Mex$386.65 | Mex$117.67 | n/a | 5 |
| Mar ’25 | n/a | Mex$303.70 0% | 21.3% | Mex$395.38 | Mex$257.86 | n/a | 3 |
| Feb ’25 | n/a | Mex$303.70 0% | 21.3% | Mex$395.38 | Mex$257.86 | n/a | 3 |
| Jan ’25 | n/a | Mex$303.70 0% | 21.3% | Mex$395.38 | Mex$257.86 | n/a | 3 |
| Dec ’24 | n/a | Mex$303.70 0% | 21.3% | Mex$395.38 | Mex$257.86 | n/a | 3 |
| Nov ’24 | n/a | Mex$378.63 0% | 38.8% | Mex$586.27 | Mex$274.81 | n/a | 3 |
| Oct ’24 | n/a | Mex$352.85 0% | 38.8% | Mex$546.35 | Mex$256.10 | n/a | 3 |
| Sep ’24 | n/a | Mex$353.82 0% | 38.8% | Mex$547.85 | Mex$256.81 | Mex$649.00 | 3 |
| Aug ’24 | n/a | Mex$346.05 0% | 38.8% | Mex$535.82 | Mex$251.17 | n/a | 3 |
| Jul ’24 | n/a | Mex$382.98 0% | 38.8% | Mex$593.00 | Mex$277.97 | n/a | 3 |
| Jun ’24 | n/a | Mex$382.98 0% | 38.8% | Mex$593.00 | Mex$277.97 | n/a | 3 |
| May ’24 | n/a | Mex$382.98 0% | 38.8% | Mex$593.00 | Mex$277.97 | n/a | 3 |
| Apr ’24 | n/a | Mex$382.98 0% | 38.8% | Mex$593.00 | Mex$277.97 | n/a | 3 |
| Mar ’24 | n/a | Mex$382.98 0% | 38.8% | Mex$593.00 | Mex$277.97 | n/a | 3 |
| Feb ’24 | n/a | Mex$400.69 0% | 38.8% | Mex$620.43 | Mex$290.82 | n/a | 3 |
| Jan ’24 | n/a | Mex$400.69 0% | 38.8% | Mex$620.43 | Mex$290.82 | n/a | 3 |
| Dec ’23 | n/a | Mex$400.69 0% | 38.8% | Mex$620.43 | Mex$290.82 | n/a | 3 |
| Nov ’23 | n/a | Mex$395.93 0% | 35.4% | Mex$593.89 | Mex$296.95 | n/a | 3 |
| Oct ’23 | n/a | Mex$587.19 0% | 1.7% | Mex$597.14 | Mex$577.24 | n/a | 2 |
| Sep ’23 | n/a | Mex$587.19 0% | 1.7% | Mex$597.14 | Mex$577.24 | n/a | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.